Mosaic ImmunoEngineering, Inc. Stock
Stocks
CPMV
US61945M1018
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
19:33:15 22/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.0600 USD | -81.98% |
|
-81.98% | -80.71% |
| Market Cap | 435K 388K 358K 325K 610K 41.16M 619K 4.31M 1.7M 21.56M 1.63M 1.6M 68.31M | P/E 2024 |
-5.39x | P/E 2025 | -3.11x |
|---|---|---|---|---|---|
| Enterprise Value | 2.1M 1.87M 1.73M 1.57M 2.94M 199M 2.99M 20.8M 8.19M 104M 7.87M 7.7M 330M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
11.32% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -81.98% | ||
| 1 week | -81.98% | ||
| Current month | -1.64% | ||
| 1 month | -1.64% | ||
| 3 months | -91.09% | ||
| 6 months | -91.37% | ||
| Current year | -80.71% |
| 1 week | 0.06 |  | 0.07 |
| 1 month | 0.06 | | 0.33 |
| Current year | 0.05 | | 0.75 |
| 1 year | 0.05 | | 0.9 |
| 3 years | 0.05 | | 1.13 |
| 5 years | 0.05 | | 3 |
| 10 years | 0.05 | | 9.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Steven King
CEO | Chief Executive Officer | 61 | 31/08/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Steven King
BRD | Director/Board Member | 61 | 21/08/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/02/22 | Others | Founder | 0 | 0% | ||
| 18/02/22 | Others | Chief Executive Officer | 0 | 0% | ||
| 18/02/22 | Others | Director | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -81.98% | -81.98% | -93.99% | -89.47% | 435K | |
| -4.10% | -8.54% | +40.05% | +66.99% | 63.29B | |
| -0.41% | +3.27% | +10.46% | +72.82% | 54.89B | |
| +0.74% | +4.04% | +12.18% | +88.71% | 53.28B | |
| +0.61% | +2.69% | +27.75% | +50.97% | 45.81B | |
| -1.08% | +2.19% | +21.92% | +131.38% | 43.46B | |
| -3.39% | -0.83% | +254.27% | +571.04% | 40.23B | |
| -1.67% | +6.70% | +14.42% | +56.67% | 33.45B | |
| +2.47% | -3.86% | +30.54% | +0.41% | 23.7B | |
| +1.30% | +4.94% | +38.23% | +28.59% | 23.76B | |
| Average | -8.76% | +0.95% | +35.58% | +97.81% | 38.19B | |
| Weighted average by Cap. | -0.96% | +0.89% | +47.99% | +121.94% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -922K -823K -759K -690K -1.29M -87.33M -1.31M -9.15M -3.6M -45.76M -3.46M -3.39M -145M | -688K -614K -566K -515K -965K -65.16M -980K -6.82M -2.69M -34.14M -2.58M -2.53M -108M |
| Net Debt | 1.48M 1.32M 1.22M 1.11M 2.07M 140M 2.11M 14.66M 5.77M 73.32M 5.55M 5.43M 232M | 1.66M 1.48M 1.37M 1.24M 2.33M 157M 2.37M 16.49M 6.5M 82.49M 6.24M 6.11M 261M |
Employees
5
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- CPMV Stock
Select your edition
All financial news and data tailored to specific country editions
